All News #Library
Biotech
Clarity Inks Deal For Cu-64 Sar-Bispsma Manufacturing
14 Apr 2026 //
PR NEWSWIRE
Co-Psma Data Published In The European Urology Journal
31 Mar 2026 //
PR NEWSWIRE
Clarity Inks Major Copper-64 Supply Deal With Theragenics
25 Mar 2026 //
PR NEWSWIRE
Another SECuRE Participant with Undetectable PSA, Negative Biopsy
23 Feb 2026 //
PR NEWSWIRE
SECuRE Trial Proceeds Unchanged Post Safety Review Meeting
15 Jan 2026 //
PR NEWSWIRE
SECuRE trial: First patient treated in Phase II Expansion
15 Apr 2025 //
PR NEWSWIRE
Positive FDA Guidance On 64Cu-SAR-bisPSMA Phase III Trial
14 Oct 2024 //
PR NEWSWIRE
First Participant Treated Using NorthStar Med Radioisotopes’ (Cu-67)
28 Aug 2023 //
BUSINESSWIRE

Market Place
Sourcing Support